Shell plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Shell plc (incorporated in England and Wales) covers share repurchase transactions conducted during March 2025. The report was filed on April 1, 2025. The transactions relate to the Company's ongoing share buy-back programme announced on January 30, 2025, which is authorized to run until April 25, 2025. Trading decisions for this period are executed independently by Natixis within pre-set parameters.
Key Financial Metrics: Share Repurchases
The filing details daily share purchases for cancellation across multiple trading venues (LSE, Chi-X, BATS, XAMS, CBOE DXE, TQEX) in both GBP and EUR. The filing does not provide consolidated revenue, profit, cash flow, or debt metrics for the period.
| Date | Total Shares Purchased (Approx.) | Primary Venues | Currencies |
|---|---|---|---|
| March 3, 2025 | 1,560,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 4, 2025 | 3,350,250 | LSE, XAMS, Chi-X, BATS, CBOE DXE, TQEX | GBP, EUR |
| March 5, 2025 | 2,100,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 6, 2025 | 1,607,738 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 7, 2025 | 1,575,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 10, 2025 | 1,575,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 11, 2025 | 1,675,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 12, 2025 | 1,232,096 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 13, 2025 | 485,845 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 14, 2025 | 608,535 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 17, 2025 | 364,769 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 18, 2025 | 1,300,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 19, 2025 | 951,988 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 20, 2025 | 1,300,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 21, 2025 | 1,750,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE, TQEX | GBP, EUR |
| March 24, 2025 | 1,200,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 25, 2025 | 1,400,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 26, 2025 | 524,501 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 27, 2025 | 1,595,025 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 28, 2025 | 2,250,000 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
| March 31, 2025 | 1,392,176 | LSE, XAMS, Chi-X, BATS, CBOE DXE | GBP, EUR |
Note: Total shares purchased in March 2025 approximate 24.5 million shares based on the sum of daily transactions listed.
Material Changes and Trends
The filing does not provide comparative financial data against prior periods. However, the share price data indicates volatility during the month:
- GBP Share Price Range: Purchases occurred between a low of approximately £25.09 (March 6) and a high of £28.30 (March 26).
- EUR Share Price Range: Purchases occurred between a low of approximately €30.14 (March 6) and a high of €34.11 (March 27).
- Volume Fluctuation: Daily purchase volumes varied significantly, ranging from approximately 364,000 shares (March 17) to over 3.3 million shares (March 4).
Guidance, Outlook, and Management Commentary
The filing confirms the continuation of the share buy-back programme announced on January 30, 2025. The programme includes both on-market and off-market limbs and is scheduled to conclude on April 25, 2025. Trading is being executed by Natixis in accordance with the UK Listing Rules (Chapter 9) and the Market Abuse Regulation (EU MAR and UK MAR). No specific financial guidance or outlook regarding future earnings or cash flow is provided in this document.
Investor Verification Checklist
- Programme Status: Verify the total cumulative amount spent and shares repurchased under the January 30, 2025 programme to date.
- Remaining Authority: Confirm the remaining authorization limit for the buy-back programme as it approaches the April 25, 2025 deadline.
- Share Count Impact: Assess the impact of the ~24.5 million shares repurchased in March on the total outstanding share count and earnings per share (EPS).
- Cost Basis: Calculate the weighted average cost of the March repurchases to evaluate capital allocation efficiency relative to current market prices.
- Regulatory Compliance: Ensure all transactions adhered to the pre-set parameters and trading windows as required by UK and EU market abuse regulations.